Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $544.07 | 5 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $419.72 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $124.35 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $326.81 | 3 | Gilead Sciences, Inc. ($202.46) |
| 2022 | $121.41 | 1 | Gilead Sciences, Inc. ($121.41) |
| 2021 | $95.85 | 1 | Gilead Sciences, Inc. ($95.85) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $104.05 | General |
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $124.35 | General |
| 04/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $98.41 | General |
| 11/17/2022 | Gilead Sciences, Inc. | Descovy (Drug) | Food and Beverage | In-kind items and services | $121.41 | General |
| Category: HIV | ||||||
| 06/23/2021 | Gilead Sciences, Inc. | Descovy (Drug) | Food and Beverage | In-kind items and services | $95.85 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 86 | 89 | $8,885 | $3,462 |
| 2022 | 3 | 83 | 87 | $8,939 | $4,386 |
| 2021 | 6 | 150 | 150 | $11,549 | $6,798 |
| 2020 | 5 | 82 | 82 | $6,496 | $3,563 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 36 | 36 | $4,284 | $1,734 | 40.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 39 | $4,251 | $1,517 | 35.7% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 13 | 14 | $350.00 | $211.36 | 60.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 34 | 34 | $3,956 | $1,956 | 49.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 32 | $3,408 | $1,358 | 39.9% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 20 | 21 | $1,575 | $1,071 | 68.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 47 | 47 | $5,123 | $2,950 | 57.6% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 27 | 27 | $2,025 | $1,385 | 68.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 26 | 26 | $2,554 | $1,314 | 51.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 11 | 11 | $659.89 | $659.89 | 100.0% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 24 | 24 | $887.00 | $245.53 | 27.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 15 | 15 | $300.00 | $242.85 | 81.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 31 | 31 | $3,379 | $1,958 | 57.9% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 13 | 13 | $649.87 | $649.87 | 100.0% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 12 | 12 | $1,188 | $546.34 | 46.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 15 | 15 | $300.00 | $241.05 | 80.4% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 11 | 11 | $979.00 | $167.75 | 17.1% |
About Laura Dermody
Laura Dermody is a Family healthcare provider based in Fairfield, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2013. The National Provider Identifier (NPI) number assigned to this provider is 1801237565.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Laura Dermody has received a total of $544.07 in payments from pharmaceutical and medical device companies, with $326.81 received in 2024. These payments were reported across 5 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($544.07).
As a Medicare-enrolled provider, Dermody has provided services to 401 Medicare beneficiaries, totaling 408 services with total Medicare billing of $18,209. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Fairfield, OH
- Active Since 07/10/2013
- Last Updated 07/10/2013
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1801237565
Products in Payments
- Descovy (Drug) $217.26
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Fairfield
Laurie Bresee
Family — Payments: $11,797
Ayisha Ilias, Fnp-C, FNP-C
Family — Payments: $6,729
Mr. Manuel Marquez, Fnp, FNP
Family — Payments: $6,505
Todd Clark, Aprn, APRN
Family — Payments: $4,297
Mr. Stephen Rogers, Fnp-C, FNP-C
Family — Payments: $4,208
Ms. Jillian Ross, A.p.r.n, A.P.R.N
Family — Payments: $3,749